AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
Atropos Health and Guidehouse Bring Point-of-Care Clinical Decision Support to Life Sciences
Atropos Health and Guidehouse are launching a point-of-care clinical decision support offering aimed at life sciences customers. The product points to growing demand for evidence generation tools that can influence decisions closer to the bedside.
FDA Opens the Door to De-Identified Real-World Evidence in Regulatory Filings
The FDA has issued guidance that makes de-identified real-world evidence more usable in regulatory submissions, potentially broadening the data sources companies can bring to market. For drug and device developers, this could reduce reliance on traditional trials in some contexts while increasing pressure to prove data quality and provenance.
Diagens Sets a Benchmark for Real-World Clinical Performance in Medical Foundation Models
Diagens says it has established a global benchmark for real-world clinical performance in a medical foundation model, signaling a shift from laboratory-style scoring to deployment-oriented validation. The announcement reflects growing pressure on AI vendors to prove usefulness in actual clinical settings, not just curated test sets.
OM1’s Massive Real-World Dataset Could Set a New Standard for FDA Evidence Packages
OM1 says it supported FDA approval of Hologic’s Aptima HPV assay with a real-world submission based on data from 650,000 patients. The scale of the dataset underscores how real-world evidence is shifting from a nice-to-have supplement to a core regulatory asset.
OM1’s 650,000-Patient Real-World Submission Shows Evidence Generation Is Becoming an AI Problem Too
OM1 supported a regulatory submission for Hologic’s Aptima HPV assay using real-world data from 650,000 patients, highlighting the scale now required to make a persuasive evidence case. The submission reflects a growing trend in which data infrastructure and analytics are becoming central to regulatory strategy.
NPR says AI did better than ER doctors in a real-world diagnosis test — and that raises the bar for adoption
NPR highlighted a real-world test in which an AI model outperformed emergency room doctors at diagnosing patients, underscoring how quickly clinical AI is moving from theory to practice. The result strengthens the case for AI as a diagnostic aid, but it also sharpens the need for guardrails, validation, and governance.
Four Hundred Thousand AI-Processed Scans Offer a Real-World Stress Test for Imaging Automation
A five-year experiment involving 400,000 AI-processed imaging studies offers one of the clearest looks yet at how imaging automation performs outside the lab. The scale makes it especially relevant for buyers trying to understand what sustained deployment actually looks like. The lesson is likely less about a single model and more about the operational reality of using AI across changing patient populations, workflows, and institutions.
Massive Bio Claims a Landmark Trial-Matching Study Shows AI Can Scale Cancer Access
Massive Bio says a prospective study in 3,804 cancer patients demonstrates that AI-driven trial matching can work at real-world scale, not just in curated demonstrations. If the results hold up, the study could strengthen the case that AI can reduce one of oncology’s most persistent access bottlenecks: finding eligible patients for trials fast enough to matter.
Massive Bio Says AI Can Match Thousands of Cancer Patients to Clinical Trials at Scale
Massive Bio says a prospective study involving 3,804 cancer patients shows AI-driven trial matching can work at scale. The finding addresses one of oncology’s most persistent bottlenecks: how to connect eligible patients to trials fast enough to matter.
Atropos Health Pushes Precision Evidence Toward a Broader Clinical Use Case
Atropos Health says it has published a methodology to expand precision evidence content, a move that highlights the growing demand for decision support built on real-world data. The company is aiming to make evidence generation more reusable and more clinically relevant.
AI Finds Drug Safety Signals Hidden in Clinical Notes
Vanderbilt researchers are using AI to detect drug safety signals from clinical notes, expanding pharmacovigilance beyond structured adverse-event reporting. The work points to a future where unstructured text becomes a more important source of post-market safety intelligence.
Vanderbilt Study Shows AI Can Surface Drug Safety Signals Hidden in Clinical Notes
Vanderbilt University Medical Center says its researchers have built an AI approach that can detect drug safety signals buried in unstructured clinical notes. The work points to a larger shift in pharmacovigilance: moving beyond claims and spreadsheets to the messy realities of real-world documentation.
Real-World Evidence and Change Control Plans Are Emerging as the Missing Infrastructure for Adaptive Digital Health
A new analysis argues that real-world evidence and predetermined change control plans could accelerate adoption of digital health technologies, especially those that evolve after launch. The idea is increasingly central to AI regulation: if software can change, the oversight model has to account for controlled change rather than freeze products in time.
Neurophet’s ALZ-NET deal shows imaging AI scaling through research networks, not consumer channels
Neurophet will provide AI imaging tools to ALZ-NET, a move that highlights how neuroimaging AI is advancing through structured research and clinical data networks. The arrangement signals that adoption in Alzheimer’s care may depend less on flashy product launches and more on fitting into evidence-generating infrastructure.
Real-World Breast Screening Study Strengthens the Case for Autonomous AI Triage
A real-world report on autonomous AI in breast screening suggests radiologists’ workload can be reduced materially in routine practice, not just in controlled studies. That distinction is crucial for a field where many AI products perform well retrospectively but struggle to change day-to-day operations.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.